Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost

Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry

(2013) Nicolas Desbenoit et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Benzalkonium Chloride and Glaucoma

(2013) Carol A. Rasmussen et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Effects of Prostaglandin Analogues on Aqueous Humor Outflow Pathways

(2013) Nelson S. Winkler et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial

(2012) Anna M. Stevens et al.   ACTA OPHTHALMOLOGICA

Tafluprost: The First Preservative-Free Prostaglandin to Treat Open-Angle Glaucoma and Ocular Hypertension

(2012) Cory Swymer et al.   ANNALS OF PHARMACOTHERAPY

The Cytotoxic Effects of Preserved and Preservative-Free Prostaglandin Analogs on Human Corneal and Conjunctival EpitheliumIn Vitroand the Distribution of Benzalkonium Chloride Homologs in Ocular Surface TissuesIn Vivo

(2012) Pertti Pellinen et al.   CURRENT EYE RESEARCH

Localization and Expression of Zonula Occludins-1 in the Rabbit Corneal Epithelium following Exposure to Benzalkonium Chloride

(2012) Wensheng Chen et al.   PLoS One

A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in Rabbits

(2012) Françoise Brignole-Baudouin et al.   PLoS One

Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells

(2012) E. Taniguchi Ishikawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ocular Surface Disease and Quality of Life in Patients With Glaucoma

(2011) Simon E. Skalicky et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines

(2011) D. A. Ammar et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Long-term Effect of BAK-free Travoprost on Ocular Surface and Intraocular Pressure in Glaucoma Patients After Transition From Latanoprost

(2011) Makoto Aihara et al.   JOURNAL OF GLAUCOMA

Metabolism and Ocular Tissue Distribution of an Antiglaucoma Prostanoid, Tafluprost, After Ocular Instillation to Monkeys

(2011) Yasufumi Fukano et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication

(2010) Hannu Uusitalo et al.   ACTA OPHTHALMOLOGICA

Preservatives in eyedrops: The good, the bad and the ugly

(2010) Christophe Baudouin et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Disposition and Metabolism of a Novel Prostanoid Antiglaucoma Medication, Tafluprost, Following Ocular Administration to Rats

(2009) Y. Fukano et al.   DRUG METABOLISM AND DISPOSITION

Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo

(2009) Akiyasu Kanamori et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells

(2009) Seth P. Epstein et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

(2008) Christophe Baudouin   ACTA OPHTHALMOLOGICA